Literature DB >> 5923732

Amitriptyline and glaucoma.

R F Lowe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5923732

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

1.  Bilateral symptomatic angle closure associated with a regular dose of citalopram, an SSRI antidepressant.

Authors:  P Massaoutis; D Goh; P J Foster
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

Review 2.  Ocular adverse effects of neuropsychiatric agents. Incidence and management.

Authors:  T Oshika
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 3.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

4.  Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions.

Authors:  S I Davidson; I G Rennie
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 5.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

Review 6.  A review of systemic medications that may modulate the risk of glaucoma.

Authors:  Annie Wu; Anthony P Khawaja; Louis R Pasquale; Joshua D Stein
Journal:  Eye (Lond)       Date:  2019-10-08       Impact factor: 3.775

7.  Citalopram associated with acute angle-closure glaucoma: case report.

Authors:  Robert Croos; Srinivasa Thirumalai; Sabit Hassan; Jane Da Roza Davis
Journal:  BMC Ophthalmol       Date:  2005-10-04       Impact factor: 2.209
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.